MHRA Approval for First UK-made mRNA Vaccine - Scorecard - MDSpire

MHRA Approval for First UK-made mRNA Vaccine

Moderna receives MHRA approval for updated COVID-19 vaccine targeting SARS-CoV-2 variant LP.8.1

  • February 27, 2026

  • 2 min

Share

Clinical Scorecard: MHRA Approval for First UK-made mRNA Vaccine

At a Glance

CategoryDetail
ConditionCOVID-19
Key MechanismsmRNA vaccine targeting SARS-CoV-2 LP.8.1 variant
Target PopulationAdults and children aged six months and above
Care SettingPublic health vaccination campaign

Key Highlights

  • First UK-made mRNA vaccine authorized by MHRA
  • Targets the SARS-CoV-2 LP.8.1 variant
  • Supplied from the Moderna Innovation and Technology Centre in Oxfordshire
  • Supports the 2026 NHS COVID-19 vaccination campaign
  • Strengthens UK's pandemic preparedness and vaccine manufacturing capability

Guideline-Based Recommendations

Diagnosis

  • Monitor COVID-19 variants and update vaccine composition accordingly

Management

  • Administer updated Spikevax® vaccine to eligible populations

Monitoring & Follow-up

  • Evaluate vaccine efficacy against circulating variants

Risks

  • Consider potential adverse effects and public health implications of COVID-19

Patient & Prescribing Data

Adults and children aged six months and above

Updated vaccine is essential for protecting high-risk groups

Clinical Best Practices

  • Ensure timely access to updated vaccines
  • Promote vaccination campaigns targeting vulnerable populations
  • Collaborate with public health agencies for effective distribution

Related Resources & Content

Original Source(s)

MHRA Approval for First UK-made mRNA Vaccine

  • February 27, 2026

Related Content

FDA Expands CAPVAXIVE Pediatric Use

Phase 3 data showed noninferior immune responses vs pneumococcal 23-valent polysaccharide vaccine in pediatric patients at increased risk.

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

Updated COVID Shot Linked to Added Protection

Updated 2025-2026 vaccination was linked to added protection in a CDC-funded analysis that became part of a broader debate over routine vaccine monitoring.